REPL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,005,817.21

Replimune Group Insider Trading History Chart

Replimune Group Share Price & Price History

^$8.71

▲ +0.31 (3.69%)

As of 04/2/2025 04:46 PM ET

Days: 30 | 90 | 365

Replimune Group Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/16/2024	Sushil Patel	CEO	Sell	10,000	$12.42	$124,200.00	202,014
11/18/2024	Konstantinos Xynos	Insider	Sell	7,246	$10.78	$78,111.88	109,885
8/16/2024	Emily Luisa Hill	CFO	Sell	8,938	$10.18	$90,988.84	101,057
6/7/2024	Konstantinos Xynos	Insider	Sell	15,881	$7.50	$119,107.50	117,131
5/16/2024	Andrew Schwendenman	CAO	Sell	2,298	$6.47	$14,868.06	38,238
5/16/2024	Christopher Sarchi	Insider	Sell	2,218	$6.47	$14,350.46	92,252
5/16/2024	Colin A. Love	COO	Sell	17,615	$6.47	$113,969.05	777,345
5/16/2024	Philip Astley-Sparke	Chairman	Sell	37,928	$6.47	$245,394.16	1,487,350
5/16/2024	Robert Coffin	Director	Sell	11,464	$6.47	$74,172.08	1,821,872
5/16/2024	Sushil Patel	CEO	Sell	20,194	$6.47	$130,655.18	212,014
11/16/2023	Konstantinos Xynos	Insider	Sell	7,313	$10.92	$79,857.96	112,714
9/11/2023	Pamela Esposito	Insider	Sell	5,358	$20.01	$107,213.58	263,436
8/22/2023	Pamela Esposito	Insider	Sell	18,600	$20.01	$372,186.00	263,436
8/11/2023	Pamela Esposito	Insider	Sell	1,400	$20.00	$28,000.00	263,436
7/10/2023	Pamela Esposito	Insider	Sell	20,000	$21.58	$431,600.00	263,436
6/13/2023	Tanya Lewis	Insider	Sell	12,860	$24.06	$309,411.60	135,293
5/16/2023	Colin A. Love	COO	Sell	10,775	$18.05	$194,488.75	794,960
5/16/2023	Jean M Franchi	CFO	Sell	11,351	$18.05	$204,885.55	128,748
5/16/2023	Philip Astley-Sparke	CEO	Sell	17,902	$18.05	$323,131.10	1,525,278
5/16/2023	Sushil Patel	Insider	Sell	15,575	$18.05	$281,128.75	154,571
12/9/2022	Pamela Esposito	Insider	Sell	15,000	$25.03	$375,450.00	229,402
5/16/2022	Colin A. Love	COO	Sell	6,324	$14.59	$92,267.16	765,735
5/16/2022	Jean M Franchi	CFO	Sell	3,436	$14.59	$50,131.24	95,099
5/16/2022	Pamela Esposito	Insider	Sell	3,507	$14.59	$51,167.13	229,402
5/16/2022	Philip Astley-Sparke	CEO	Sell	9,632	$14.59	$140,530.88	1,401,080

See Full Table

SEC Filings (Institutional Ownership Changes) for Replimune Group (NASDAQ:REPL)

92.53% of Replimune Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Replimune Group Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	1,096,744	$13.28M	0.0%	+352.5%	1.424%
3/18/2025	California State Teachers Retirement System	42,725	$0.52M	0.0%	+25.9%	0.055%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	65,762	$0.80M	0.0%	-19.0%	0.096%
2/17/2025	Woodline Partners LP	854,309	$10.35M	0.1%	+156.6%	1.249%
2/17/2025	Velan Capital Investment Management LP	181,367	$2.20M	1.9%	N/A	0.265%
2/17/2025	Soleus Capital Management L.P.	262,500	$3.18M	0.2%	N/A	0.384%
2/17/2025	Squarepoint Ops LLC	18,482	$0.22M	0.0%	-5.5%	0.027%
2/17/2025	Two Sigma Advisers LP	170,400	$2.06M	0.0%	-9.6%	0.249%
2/17/2025	Two Sigma Investments LP	212,586	$2.57M	0.0%	+18.6%	0.311%
2/17/2025	Tang Capital Management LLC	2,700,000	$32.70M	2.2%	+125.0%	3.946%
2/17/2025	RTW Investments LP	2,065,010	$25.01M	0.4%	+82.1%	3.018%
2/17/2025	Rafferty Asset Management LLC	77,308	$0.94M	0.0%	-23.6%	0.113%
2/17/2025	Redmile Group LLC	4,905,527	$59.41M	4.1%	+2.6%	7.170%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	9,650	$0.12M	0.0%	N/A	0.014%
2/17/2025	Point72 Asset Management L.P.	283,966	$3.44M	0.0%	N/A	0.415%
2/17/2025	ProShare Advisors LLC	20,788	$0.25M	0.0%	+33.8%	0.030%
2/17/2025	Quantinno Capital Management LP	10,455	$0.13M	0.0%	N/A	0.015%
2/17/2025	MPM Bioimpact LLC	950,000	$11.50M	1.6%	N/A	1.388%
2/17/2025	Parkman Healthcare Partners LLC	869,759	$10.53M	1.4%	+13.9%	1.271%
2/17/2025	Nuveen Asset Management LLC	667,634	$8.09M	0.0%	+108.9%	0.976%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	241,570	$2.93M	0.2%	+8.3%	0.353%
2/17/2025	Omega Fund Management LLC	1,975,203	$23.92M	19.9%	-19.8%	2.887%
2/17/2025	Millennium Management LLC	1,189,662	$14.41M	0.0%	+3.0%	1.739%
2/17/2025	J. Goldman & Co LP	112,683	$1.37M	0.0%	+639.5%	0.165%
2/17/2025	Graham Capital Management L.P.	30,180	$0.37M	0.0%	+6.1%	0.044%
2/17/2025	Fcpm Iii Services B.V.	3,970,668	$48.09M	8.2%	-18.4%	5.803%
2/17/2025	D. E. Shaw & Co. Inc.	972,575	$11.78M	0.0%	+12.1%	1.421%
2/17/2025	Deutsche Bank AG	561,561	$6.80M	0.0%	+4.8%	0.821%
2/17/2025	Crestline Management LP	172,202	$2.09M	0.1%	N/A	0.252%
2/17/2025	Braidwell LP	1,477,102	$17.89M	0.5%	-51.9%	2.159%
2/17/2025	Bank of America Corp DE	24,423	$0.30M	0.0%	-77.6%	0.036%
2/17/2025	BNP Paribas Financial Markets	7,167	$87K	0.0%	-52.3%	0.010%
2/17/2025	Algert Global LLC	45,820	$0.56M	0.0%	+7.1%	0.067%
2/14/2025	Boxer Capital Management LLC	1,796,341	$21.75M	1.8%	N/A	2.625%
2/14/2025	Jane Street Group LLC	316,287	$3.83M	0.0%	+20.6%	0.462%
2/14/2025	Freestone Grove Partners LP	11,589	$0.14M	0.0%	N/A	0.017%
2/14/2025	Schonfeld Strategic Advisors LLC	163,300	$1.98M	0.0%	-71.5%	0.239%
2/14/2025	Northern Trust Corp	589,635	$7.14M	0.0%	+7.3%	0.862%
2/14/2025	The Manufacturers Life Insurance Company	194,004	$2.35M	0.0%	+5.3%	0.284%
2/14/2025	Virtus ETF Advisers LLC	5,818	$70K	0.0%	-40.3%	0.009%
2/14/2025	Voya Investment Management LLC	111,066	$1.35M	0.0%	-0.8%	0.162%
2/14/2025	Price T Rowe Associates Inc. MD	10,962,883	$132.76M	0.0%	+11.0%	16.023%
2/14/2025	Dark Forest Capital Management LP	17,816	$0.22M	0.0%	N/A	0.026%
2/14/2025	Diadema Partners LP	114,000	$1.38M	0.6%	N/A	0.167%
2/14/2025	Hsbc Holdings PLC	14,008	$0.18M	0.0%	N/A	0.020%
2/14/2025	Tower Research Capital LLC TRC	6,772	$82K	0.0%	+696.7%	0.010%
2/14/2025	MetLife Investment Management LLC	37,659	$0.46M	0.0%	+7.2%	0.055%
2/14/2025	Nan Fung Group Holdings Ltd	321,746	$3.90M	3.3%	+11.8%	0.470%
2/14/2025	Dimensional Fund Advisors LP	778,163	$9.43M	0.0%	+42.7%	1.137%
2/13/2025	Marshall Wace LLP	896,184	$10.85M	0.0%	N/A	1.310%
2/13/2025	Jump Financial LLC	71,443	$0.87M	0.0%	+95.5%	0.104%
2/13/2025	XTX Topco Ltd	11,337	$0.14M	0.0%	N/A	0.017%
2/13/2025	Barclays PLC	167,329	$2.03M	0.0%	+5.6%	0.245%
2/13/2025	Sterling Capital Management LLC	2,109	$26K	0.0%	+364.5%	0.003%
2/13/2025	Renaissance Technologies LLC	156,936	$1.90M	0.0%	+45.7%	0.229%
2/13/2025	Legal & General Group Plc	59,366	$0.72M	0.0%	+42.1%	0.087%
2/13/2025	Invesco Ltd.	88,006	$1.07M	0.0%	-51.4%	0.129%
2/13/2025	Bank of Montreal Can	12,326	$0.15M	0.0%	-11.3%	0.018%
2/13/2025	Federated Hermes Inc.	4,070	$49K	0.0%	-20.8%	0.006%
2/13/2025	Aster Capital Management DIFC Ltd	8,276	$100K	0.0%	+8,798.9%	0.012%
2/13/2025	Wells Fargo & Company MN	77,371	$0.94M	0.0%	+102.3%	0.113%
2/12/2025	Trexquant Investment LP	194,592	$2.36M	0.0%	-27.0%	0.284%
2/12/2025	Geode Capital Management LLC	1,429,666	$17.32M	0.0%	+0.1%	2.090%
2/12/2025	Alliancebernstein L.P.	440,612	$5.34M	0.0%	-9.9%	0.644%
2/12/2025	Meeder Asset Management Inc.	16,909	$0.21M	0.0%	N/A	0.025%
2/12/2025	Wellington Management Group LLP	1,096,744	$13.28M	0.0%	+352.5%	1.603%
2/12/2025	JPMorgan Chase & Co.	486,609	$5.89M	0.0%	+95.2%	0.711%
2/12/2025	Artisan Partners Limited Partnership	611,013	$7.40M	0.0%	N/A	0.893%
2/11/2025	Corebridge Financial Inc.	30,267	$0.37M	0.0%	-7.0%	0.044%
2/11/2025	Vanguard Group Inc.	3,595,848	$43.55M	0.0%	+3.7%	5.256%
2/11/2025	KLP Kapitalforvaltning AS	12,400	$0.15M	0.0%	N/A	0.018%
2/11/2025	Sei Investments Co.	12,219	$0.15M	0.0%	N/A	0.018%
2/11/2025	American Century Companies Inc.	111,850	$1.36M	0.0%	+32.2%	0.163%
2/11/2025	Rosalind Advisors Inc.	260,000	$3.15M	1.6%	N/A	0.380%
2/11/2025	Teacher Retirement System of Texas	15,603	$0.19M	0.0%	N/A	0.023%
2/10/2025	Swiss National Bank	103,700	$1.26M	0.0%	+57.4%	0.152%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	107,416	$1.30M	0.0%	-16.2%	0.157%
2/7/2025	AlphaQuest LLC	6,404	$78K	0.0%	-52.5%	0.009%
2/6/2025	Arizona State Retirement System	12,894	$0.16M	0.0%	N/A	0.019%
2/6/2025	Victory Capital Management Inc.	44,880	$0.54M	0.0%	N/A	0.066%
2/6/2025	Charles Schwab Investment Management Inc.	508,398	$6.16M	0.0%	+4.9%	0.743%
2/4/2025	Los Angeles Capital Management LLC	34,547	$0.42M	0.0%	-41.0%	0.050%
2/4/2025	Bank of New York Mellon Corp	174,518	$2.11M	0.0%	+7.3%	0.255%
1/31/2025	New York State Common Retirement Fund	43,204	$0.52M	0.0%	+260.8%	0.063%
1/30/2025	Rhumbline Advisers	95,465	$1.16M	0.0%	+8.3%	0.140%
1/24/2025	China Universal Asset Management Co. Ltd.	16,317	$0.20M	0.0%	+24.2%	0.024%
1/17/2025	SG Americas Securities LLC	26,291	$0.32M	0.0%	+14.7%	0.038%
12/26/2024	JPMorgan Chase & Co.	249,349	$2.73M	0.0%	+3.3%	0.364%
11/19/2024	Barclays PLC	158,491	$1.74M	0.0%	+165.5%	0.232%
11/16/2024	Geode Capital Management LLC	1,428,301	$15.66M	0.0%	+17.9%	2.088%
11/15/2024	Barclays PLC	158,491	$1.74M	0.0%	+165.5%	0.232%
11/15/2024	Jane Street Group LLC	262,248	$2.87M	0.0%	-51.1%	0.383%
11/15/2024	Wellington Management Group LLP	242,398	$2.66M	0.0%	-40.2%	0.354%
11/15/2024	State Street Corp	2,340,042	$25.65M	0.0%	+102.1%	3.420%
11/15/2024	Redmile Group LLC	4,781,183	$52.40M	3.1%	-14.0%	6.988%
11/15/2024	Parkman Healthcare Partners LLC	763,747	$8.37M	1.1%	+45.5%	1.116%
11/15/2024	Jacobs Levy Equity Management Inc.	39,521	$0.43M	0.0%	-52.8%	0.058%
11/15/2024	Arizona PSPRS Trust	76,100	$0.83M	0.0%	N/A	0.111%
11/15/2024	Baker BROS. Advisors LP	11,045,336	$121.06M	1.3%	+10.0%	16.143%
11/15/2024	Erste Asset Management GmbH	11,900	$0.13M	0.0%	N/A	0.017%

Data available starting January 2016

See Full Table

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors; and that has completed Phase II clinical trials for treating cutaneous squamous cell carcinoma. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

Today's Range

Now: $8.71

$8.12

$9.16

50 Day Range

MA: $12.60

$8.40

$14.31

52 Week Range

Now: $8.71

$4.92

$17.00

Volume

1,147,608 shs

Average Volume

862,377 shs

Market Capitalization

$670.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.3

Who are the company insiders with the largest holdings of Replimune Group?: Replimune Group's top insider shareholders include:
Robert Coffin (Director)
Philip Astley-Sparke (CEO)
Philip Astley-Sparke (Chairman)
Colin Love (COO)
Pamela Esposito (Insider)
Sushil Patel (CEO)
Sushil Patel (Insider)
Tanya Lewis (Insider)
Jean M Franchi (CFO)
Konstantinos Xynos (Insider)
Emily Luisa Hill (CFO)
Christopher Sarchi (Insider)
Andrew Schwendenman (CAO)
Learn More about top insider investors at Replimune Group.